Compassionate-use lurbinectedin demonstrates modest yet consistent efficacy and is well tolerated in patients with ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

U nder the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical ...

The efficacy and safety of currently approved and pipeline medications for moderate-to-severe hidradenitis suppurativa (HS) ...

Panelists discuss the ELEVATE trial’s ongoing evaluation of lasofoxifene combined with targeted agents such as ribociclib, ...

KALA Bio completes enrollment in CHASE trial, advancing KPI-012 for treating persistent corneal epithelial defects. Topline ...

U pstream Bio has dosed the first subject in the randomised Phase II trial of verekitug, an antibody antagonist targeting the ...

Cornerstone Robotics (CSR) has announced the first formal clinical investigation of its Hong Kong-developed surgical robotic ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

The platform additionally supports concurrent efficacy testing through human tumor co-engraftment and dose ranging studies, helping define the therapeutic window and optimize clinical trial design.

Hemlibra safely reduces bleeding episodes in people with hemophilia A without inhibitors, per a review study that confirmed ...

Two international clinical studies led by PD Dr Norbert Heinrich at the Institute of Infectious Diseases and Tropical Medicine at LMU University Hospital Munich with international partners have shown ...